Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Elias Jabbour Guillermo Garcia-Manero Pierre Fenaux Bart L Scott Aref Al-Kali Lucy A Godley Uwe Platzbecker Hagop Kantarjian Gail J Roboz Ehab Atallah Lewis B Silverman David P. Steensma Mikkael A Sekeres Gianluca Gaidano Everett Peter Greenberg |
| Publication date | March 8, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |